Stay updated on AEB1102 in Arginase I Deficiency Clinical Trial
Sign up to get notified when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.

Latest updates to the AEB1102 in Arginase I Deficiency Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoChange DetectedA site-wide notice was added announcing NIH website transition updates and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check15 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the page displaying a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error page with a Home link. This replaces the usual study details with an access-denied notice.SummaryDifference0.5%

- Check43 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study content. This replaces the study details and navigation with an access-denied message.SummaryDifference17%

Stay in the know with updates to AEB1102 in Arginase I Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AEB1102 in Arginase I Deficiency Clinical Trial page.